Navigation Links
Infants Malarial Risk Lowered by Preventive Measures

As a preventive measure, single dose of a common anti-malarial drug could help to reduce the risk of developing malaria in infants – study finds//.

According to a new study, intermittent preventive measures of giving anti-malarial drugs to 3, 4, and 9-month old-infants lowered their risk of contracting malaria in the future.

Malaria is one of the leading causes of death worldwide, causing an estimated 3,000 deaths each day and at least 300 million cases of severe illness each year, particularly among infants in sub-Saharan Africa. Prior attempts at prevention that relied on frequent administration of antimalarial drugs were unaffordable in the long run and might promote drug resistance. But intermittent preventive treatment, a more focused use of antimalarials at a few specific intervals, has proved promising in earlier studies.

Clara Menendez, MD, and her colleagues in Mozambique and Spain explored the intermittent administration of the antimalarial sulfadoxine-pyrimethamine (SP) to infants in their first year. Infants given SP at 3, 4, and 9 months of age were compared with those given a placebo at the same intervals.

Dr. Menendez and colleagues found that giving infants SP was safe and well tolerated, and reduced the incidence of hospital admissions by one fifth.

According to editorialists Feiko O. ter Kuile, MD, PhD, of the Liverpool School of Tropical Medicine and the U.S. Centers for Disease Control and Prevention, and Richard W. Steketee, MD, MPH, of the Malaria Control and Evaluation Partnership in Africa, ‘SP has a combination of features that may make it highly suitable for use as intermittent preventive treatment; it has relatively long half-lives, is very well tolerated in young infants, and it can be given as a single dose.’

Intermittent preventive treatment with sulfadoxine-pyrimethamine is seen by Drs. ter Kuile and Steketee to provide a satisfactory balance of safety and efficacy. There is
'"/>




Page: 1 2

Related medicine news :

1. Banning Smoking in the Home Helps Infants
2. Benefits of Nitric Oxide in the Treatment of Premature Infants
3. New Technique to Study Infants Brain.
4. Limiting Infants Exposure To Smoke At Home
5. fMRI Offers Insight Into An Infants Brain
6. Drug Used To Improve Lung Function In Infants Could Slow Down Motor Coordination
7. Infants going to day-care may have lower risk of leukemia
8. Infants at lower risk from digestive disease if introduced to cereal early
9. New Blood Test To Detect Iron Level In Infants
10. Infants must be put to sleep in separate beds to prevent SIDS
11. Plump Infants Getting Obese Later In Life In More Cases
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Infants Malarial Risk Lowered Preventive Measures

(Date:7/26/2014)... can provide much-needed relief from the summer heat, but ... much chlorinated water, experts warn. Amid the splashing ... water in their mouth. Some kids may even take ... parents. Although swallowing a small amount of pool ... that ingesting too much can lead to chlorine poisoning ...
(Date:7/26/2014)... (PRWEB) July 26, 2014 As reported ... on July 23rd, new research by Palo Alto Networks ... rewrite their playbook, now focusing more on businesses and ... who have become increasingly wise to their tactics over ... and CEO/CTO, Joe Caruso, talks about the evolution of ...
(Date:7/26/2014)... Multiple sclerosis (MS), also known as ... disease in which the insulating covers of nerve ... damaged. This damage disrupts the ability of parts ... a wide range of signs and symptoms, including ... takes several forms, with new symptoms either occurring ...
(Date:7/26/2014)... Kentucky (PRWEB) July 26, 2014 ... on the playing field; however, concussions in ... injuries. The occupations with the highest risk of ... ,     Firefighters ,     Police officers , ... workers ,     Delivery personnel , ...
(Date:7/26/2014)... As the category creator and world ... Xoçai is to transform and improve ... chocolate products. One such unique element is XoVita™, ... and blueberries, an ingredient combination exclusive to Xoçai. ... in all of Xoçai products and provides a ...
Breaking Medicine News(10 mins):Health News:Don't Let Kids Drink Pool Water 2Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 2Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 3Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 4Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 5Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 6Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 2Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 3Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 4Health News:KORT Physical Therapists Take the Mystery Out of Identifying and Treating Workplace Head Injuries 2Health News:KORT Physical Therapists Take the Mystery Out of Identifying and Treating Workplace Head Injuries 3Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 2Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 3Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 4
... Pa., Nov. 24 WPCS International,Incorporated (Nasdaq: ... services for,specialty communication systems and wireless infrastructure, has ... $9 million in,new contracts. The contracts include projects ... Office of Emergency Management, YMCA, Group,Health Tacoma, UPS, ...
... ARAY ), a global leader in the field of radiosurgery, ... 20th Annual Piper Jaffray,Health Care Conference in New York City, ... PST). , A live ... relations page of the Company,s Web site at http://www.accuray.com ...
... 24 According to a new survey released,today, the vast majority ... percent -- are not taking the most basic steps of determining ... test if they are at,risk or taking the appropriate actions as ... baseline among Americans on their level of awareness and,knowledge regarding type ...
... Fight Against AIDS with their "Love for Life" Limited Edition ... 24 ALDO, a global fashion footwear and accessories ... program of the global health organization Population Services International, continues ... bracelets. ALDO has given more than $10 million ...
... of Drugs with Broad Potential to Treat Life-Threatening Viral Infections-- ... Agent Bavituximab and Equivalent Antibodies Cured Lethal Viral Infections in ... Confirms PS is a ,Druggable, Target Common to a Number ... TUSTIN, Calif., Nov. 24 Peregrine Pharmaceuticals, Inc. (Nasdaq: ...
... Cepheid,(Nasdaq: CPHD ) today announced that ... its Xpert(TM) MRSA/SA Skin and Soft Tissue (SSTI) ... (MRSA) and,Staphylococcus aureus (SA, typically Methicillin-sensitive) in skin ... MRSA/SA SSTI test is expected to,empower Canadian physicians ...
Cached Medicine News:Health News:WPCS Announces $9 Million in New Contracts 2Health News:Accuray Incorporated to Present at 20th Annual Piper Jaffray Health Care Conference 2Health News:New Survey Shows Majority of Americans Need to Take Proper Steps to Manage Diabetes Risk 2Health News:New Survey Shows Majority of Americans Need to Take Proper Steps to Manage Diabetes Risk 3Health News:New Survey Shows Majority of Americans Need to Take Proper Steps to Manage Diabetes Risk 4Health News:ALDO Supports World AIDS Day by Donating 100% of Proceeds for Newest 'ALDO Fights Aids' Product 2Health News:ALDO Supports World AIDS Day by Donating 100% of Proceeds for Newest 'ALDO Fights Aids' Product 3Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 2Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 3Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 4Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 5Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 6Health News:Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S. aureus Soft Tissue Infections 2Health News:Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S. aureus Soft Tissue Infections 3Health News:Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S. aureus Soft Tissue Infections 4
(Date:7/24/2014)... 24, 2014  Restore Health, a leading personalized ... announced that it is now offering pharmacogenetics testing ... individual based upon their particular genetic makeup. Comprehensive ... interaction between a patient,s genetics and their entire ... to provide this new service to healthcare providers ...
(Date:7/24/2014)... , Germany , and ... -- , Exclusive global license ... for SF3B1 mutations, including next-generation sequencing (NGS) gene panels, ... to be targeted by new test, indicate favorable prognosis ... syndromes  QIAGEN sees potential for developing companion ...
(Date:7/24/2014)... CITY, Calif., July 24, 2014  Abaxis, Inc. (NasdaqGS: ... point-of-care blood analysis systems, today reported financial results for ... First quarter overview: , Revenues of $47.5 ... , Diluted EPS of $0.21, up 50% over last ... Medical market revenues of $7.2 million, up 20% over ...
Breaking Medicine Technology:Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 3QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 2QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 3QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 4QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11
... Intercept Pharmaceuticals, Inc., has announced that its first-in-class farnesoid ... endpoint of improved insulin sensitization in a 6 week ... patients with nonalcoholic fatty liver disease (NAFLD). , By ... that a single oral daily dose of INT-747 statistically ...
... , ST. PAUL, Minn., Oct. 1 Algos Therapeutics ... today announces the selection of Dr. Ganesh Iyer as ... his new responsibilities immediately. , "We were incredibly fortunate ... Dr. Iyer to lead Algos," stated Gary Smaby, Algos ...
Cached Medicine Technology:Intercept Pharmaceuticals' FXR Agonist INT-747 Meets Primary Endpoint in a Phase II Clinical Trial in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease 2Algos Attracts CRO Veteran Dr. Ganesh Iyer as its New CEO 2
Stainless steel bone clamp....
Reduction Forceps with Points for precise reduction of bone fragments with minimal soft tissue contact....
Designed for proximal femoral elevation in total hip replacement or in other surgery with a similar need for bone manipulation....
Straight double action bone cutting rongeur....
Medicine Products: